In what makes Abbott Laboratories a serious competitor is the much lower price one has to pay for FreeStyle Libre - in comparison to Dexcom's G6 (or G7) and also in comparison to Medtronic's Guardian.

Available Dexcom CGM products include: Dexcom G6 (adults and children 2 years and ... specific health needs, and cost.

BofA raised the firm’s price target on DexCom (DXCM) to $90 from $80 and keeps a Buy rating on the shares post the Q3 report. DexCom did ...

Its innovative devices like the G6 and ... pricing and cost pressures possibly driven by competition, as well as innovations in related medical fields. Despite these challenges, DexCom maintained ...

Second, Dexcom's latest, the G7, can be manufactured at significantly lower-cost, which offers flexibility ... and faster warm-up time than G6. Medicare's decision to reimburse for the G6 and ...

Signos' platform works with Dexcom's G6 CGM and the newer G7 CGM ... Signos said users who have been diagnosed with type 2 diabetes may be able to get the cost of the CGM covered by their insurer. But ...

A class action lawsuit was filed against DexCom, Inc. (DXCM ... the gross margin guidance reflected the conversion from the G6 to the G7 CGM model. Additionally, during the Q1 FY24 report ...

Oppenheimer analyst Steven Lichtman lowered the firm’s price target on DexCom (DXCM) to $105 from $115 and keeps an Outperform rating on ...

The introduction of sensors like G6 and G7 in international markets also fueled revenue growth. Dexcom anticipates strong growth from its recent product launches and international expansions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...